Skip to main content

Table 1 Sociodemographic characteristics of the patients’ sample

From: Assessment of depression severity with the PHQ-9 in cancer patients and in the general population

 

Total (N = 2,059)

Males (N = 1,210)

Females (N = 849)

 

N

%

N

%

N

%

Age Mean (SD) in years

62.4

(14.2)

64.8

(11.9)

59.1

(16.4)

Age category

      

 18-35 y.

141

6.8

53

4.4

88

10.4

 36-45 y.

138

6.7

30

2.5

108

12.7

 46-55 y.

233

11.3

108

8.9

125

14.7

 56-65 y.

498

24.2

333

27.5

165

19.4

 66-75 y.

788

38.3

544

45.0

244

28.7

 76-94 y.

261

12.7

142

11.7

119

14.0

Diagnosis

      

 Prostate

640

31.1

640

52.9

0

0.0

 Breast

346

16.8

3

0.2

343

40.4

 Colon

196

9.5

91

7.5

105

12.4

 Kidney

119

5.8

68

5.6

51

6.0

 Bladder

91

4.4

71

5.9

20

2.4

 Rectum

90

4.4

56

4.6

34

4.0

 Hodgkin lymphoma

64

3.1

28

2.3

36

4.2

 Stomach

53

2.6

35

2.9

18

2.1

 Ovary

41

2.0

0

0.0

41

4.8

 Testis

35

1.7

35

2.9

0

0.0

 Other non-Hodgkin lymphoma

31

1.5

17

1.4

14

1.6

 Pancreas

31

1.5

21

1.7

10

1.2

 Oesophagus

30

1.5

26

2.1

4

0.5

 Non-follicular lymphoma

30

1.5

16

1.3

14

1.6

 Thyroid gland

29

1.4

8

0.7

21

2.5

 Others

233

11.3

95

7.9

138

16.3

Number of tumors

      

 1

1,851

89.9

1,084

89.6

767

90.3

 ≥2

208

10.1

126

10.4

82

9.7

Surgery

      

 no

208

10.1

110

9.1

98

11.5

 yes

1,851

89.9

1,100

90.9

751

88.5

Radiation

      

 no

1,424

69.2

973

80.4

451

53.1

 yes

635

30.8

237

19.6

398

46.9

Chemotherapy

      

 no

1,326

64.4

908

75.0

418

49.2

 yes

733

35.6

302

25.0

431

50.8

Endocrine therapy

      

 no

1,782

86.5

1,142

94.4

640

75.4

 yes

277

13.5

68

5.6

209

24.6

Antibody therapy

      

 no

1,934

93.9

1,166

96.4

768

90.5

 yes

125

6.1

44

3.6

81

9.5